[1] |
WANG Jie, LI Long, CHEN Feng, LIU Shengfei.
Research progress of nuclear factor erythroid 2-related factor 2 in pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1067-1072.
|
[2] |
QI Xiaofeng, LUO Yali, XIAO Mengyong, ZHOU Shiqin, ZHOU Wen, AN Fangyu, WEI Benjun, LIU Yongqi.
Research status of dialectical prevention and treatment of acute lung injury based on the theory of "Wei qi and Ying Xue"
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 429-437.
|
[3] |
WEI Zhenzhen, SUI Hua, JIANG Yulang, SUN Mingyu, YAN Huaru, WANG Ziyuan.
Research on the molecular mechanism of Zuo Jin Wan combined with cetuximab inducing ferroptosis in KRAS mutant colorectal cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 130-137.
|
[4] |
ZHANG Lei, XIAO Xingpeng, DING Huang .
Silencing ZKSCAN3 gene expression aggravates lung injury induced by LPS in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 164-170.
|
[5] |
ZHANG Jingyu, WANG Yihan, LI Jun, JIN Ping, SHEN Xiping, WANG Yingbin, LIU Jieting.
Involvement of autophagy in iron ion regulation promotes ferroptosis in cells undergoing intestinal ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 36-41.
|
[6] |
WANG Kai, SONG Min, SONG Zhijing, LI Jinyi.
Mechanism of vascular endothelial cells ferroptosis in cervical spondylosis of vertebral artery type
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 588-594.
|
[7] |
LI Wenxia, FANG Liuyuan, QIAN Shenxian.
Mechanism of ferroptosis and its research progress in lymphoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 314-321.
|
[8] |
HE Liyang, WEI Wenjie, YIN Qin, LIU Lijing, ZHONG Boying, LIU Cungen, ZHOU Meiling, HE Jianbin.
Preventive and therapeutic effects of the Kiwi fruit essence (unsaturated fatty acid of actinidia chinesis planch seed oil) on radiation-induced lung injury rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 154-162.
|
[9] |
ZHANG Liang, LIAO Yongqun, XIA Qinchuan, ZHOU Shitong, LI Xiaoli.
Ferroptosis regulatory signaling pathway and its research progress in related diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 227-234.
|
[10] |
GUO Yuting, LI Shanshan, LI Qinglin.
Tianma Gouteng Yin protects rotenone-induced PC12 cell damage by inhibiting ferroptosis-lipid metabolism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 8-14.
|
[11] |
PENG Jing, SONG Jing, LUAN Jiajie.
Mesenchymal Stem Cells: a new discovery in the treatment of novel coronavirus pneumonia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1073-1079.
|
[12] |
ZHANG Tianxue, ZHANG Lei, HAO Yingxiang, GAO Mingjing, WU Lin, LENG Yufang.
Effect of SLC7A11 in dexmedetomidine pretreatment induced reduction of ferroptosis caused by intestinal ischemia-reperfusion injury in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 738-743.
|
[13] |
WANG Youlin, LI Shanshan, WANG Meng, GUO Yuting, CHENG Hui, TIAN Shasha, LI Qinglin.
Gastrodin inhibits H2O2-induced ferroptosis of PC12 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 532-538.
|
[14] |
HAN Qiaoling, PING Yi.
Prospect of mesenchymal stem cell microvesicles repairing pelvic floor organ prolapse by antioxidant stress
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 594-600.
|
[15] |
ZHOU Yiwen, PING Yi.
Research progress on the mechanism and treatment of pelvic organ prolapse
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 595-600.
|